A new topical anesthetic which contains 5% lidocaine and a disinfection ingredient has been developed and is tested in this study (LidoDyn). The study examines the efficacy of LidoDyn by comparing it with an already proven anesthetic agent (EMLA crème).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
Application of 2 gram of LidoDyn to the skin surface the patient's antecubital fossa 60 min prior to venipuncture
Application of 2 gram of EMLA creme to the skin surface the patient's antecubital fossa 60 min prior to venipuncture
Emergency Department of the Meyer Children Hospital, Rambam Health Care Campus
Haifa, Israel
Self report assessment of pain (using the Visual Analog Scale)
Time frame: 60 Min+ 5-10 Min
Medical staff observational assessment of pain (in a scale of 0 to 10)
Time frame: 60 Min + 5-10 Min
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.